miR‐10b‐5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes

Abstract

AbstractBackground/AimDiabetes has substantive co‐occurrence with disorders of gut‐brain interactions (DGBIs). The pathophysiological and molecular mechanisms linking diabetes and DGBIs are unclear. MicroRNAs (miRNAs) are key regulators of diabetes and gut dysmotility. We investigated whether impaired gut barrier function is regulated by a key miRNA, miR‐10b‐5p, linking diabetes and gut dysmotility.MethodsWe created a new mouse line using the Mb3Cas12a/Mb3Cpf1 endonuclease to delete mir‐10b globally. Loss of function studies in the mir‐10b knockout (KO) mice were conducted to characterize diabetes, gut dysmotility, and gut barrier dysfunction phenotypes in these mice. Gain of function studies were conducted by injecting these mir‐10b KO mice with a miR‐10b‐5p mimic. Further, we performed miRNA‐sequencing analysis from colonic mucosa from mir‐10b KO, wild type, and miR‐10b‐5p mimic injected mice to confirm (1) deficiency of miR‐10b‐5p in KO mice, and (2) restoration of miR‐10b‐5p after the mimic injection.ResultsCongenital loss of mir‐10b in mice led to the development of hyperglycemia, gut dysmotility, and gut barrier dysfunction. Gut permeability was increased, but expression of the tight junction protein Zonula occludens‐1 was reduced in the colon of mir‐10b KO mice. Patients with diabetes or constipation‐ predominant irritable bowel syndrome, a known DGBI that is linked to leaky gut, had significantly reduced miR‐10b‐5p expression. Injection of a miR‐10b‐5p mimic in mir‐10b KO mice rescued these molecular alterations and phenotypes.ConclusionsOur study uncovered a potential pathophysiologic mechanism of gut barrier dysfunction that links both the diabetes and gut dysmotility phenotypes in mice lacking miR‐10b‐5p. Treatment with a miR‐10b‐5p mimic reversed the leaky gut, diabetic, and gut dysmotility phenotypes, highlighting the translational potential of the miR‐10b‐5p mimic.